Warenbezeichnung

Adderall XR 10mg: A Complete Guide to ADHD Management

Introduction

Adderall XR 10mg is a once-daily, extended-release formulation of mixed amphetamine salts, a central nervous system (CNS) stimulant . It is a prescription medication specifically approved for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients aged 6 and older .

Manufactured by Shire US Inc., Adderall XR uses a unique dual-bead delivery system that provides a prolonged release of medication throughout the day, helping to manage ADHD symptoms from morning through the afternoon with a single dose . For more information on ADHD treatment options and medication management, visit our website.

Product Identification

Adderall XR 10mg capsules are distinct and easily identifiable by the following physical characteristics :

The extended-release capsules contain a combination of four amphetamine salts, providing a total amphetamine base equivalence of 6.3 mg per 10 mg capsule .

How Adderall XR Works

Adderall XR 10mg is a CNS stimulant that works by increasing the activity of certain neurotransmitters in the brain, specifically dopamine and norepinephrine . The extended-release formulation contains two types of drug-releasing beads designed to give a double-pulsed delivery of amphetamines. This mechanism provides a prolonged effect, allowing for once-daily dosing .

Indications and Usage

Adderall XR 10mg is specifically indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) . Clinical studies have established its efficacy across different age groups :

• Children (ages 6-12): Efficacy demonstrated in a 3-week outpatient controlled trial

• Adolescents (ages 13-17): Efficacy established in a 4-week controlled trial

• Adults: Efficacy confirmed in a 4-week controlled trial

Dosage and Administration

Recommended Starting Dose

For pediatric patients aged 6 to 17 years, the recommended starting dose of Adderall XR is 10 mg once daily in the morning .

General Administration Guidelines

• Timing: Adderall XR should be taken once daily in the morning upon awakening. Afternoon doses should be avoided because of the potential for insomnia .

• Swallowing: Capsules should be swallowed whole with water or other liquids .

• Alternative Administration: For patients who cannot swallow the capsule, it may be opened and the entire contents sprinkled over a spoonful of applesauce. The mixture should be consumed immediately without chewing, followed by a drink of water or other liquid .

• With or Without Food: Adderall XR may be taken with or without food .

Dosage Adjustments for Renal Impairment

• Children (6-17 years) with severe renal impairment (GFR 15 to <30 mL/min/1.73m²): Recommended dose is 5 mg once daily. Maximum dose is 20 mg once daily .

• Adults with severe renal impairment: Recommended dose is 15 mg once daily .

• End-Stage Renal Disease (ESRD): Use is not recommended .

Dosage Titration

The dose of Adderall XR should be individualized according to the therapeutic needs and response of the patient, using the lowest effective dosage . For patients switching from immediate-release Adderall, the switch can be made at the same total daily dose taken once daily . Titration should occur at weekly intervals to achieve appropriate efficacy and tolerability .

Important Safety Information

Boxed Warning: Abuse, Misuse, and Addiction

Adderall XR carries an FDA Boxed Warning regarding the high potential for abuse, misuse, and addiction . CNS stimulants, including Adderall XR, can lead to the development of a substance use disorder, including addiction. Misuse and abuse can result in overdose and death .

Contraindications

Adderall XR is contraindicated in patients with:

• Known hypersensitivity to amphetamine or other components

• During or within 14 days following the administration of monoamine oxidase inhibitors (MAOIs)

• Advanced arteriosclerosis

• Symptomatic cardiovascular disease

• Moderate to severe hypertension

• Hyperthyroidism

• Glaucoma

• Agitated states

• History of drug abuse

Warnings and Precautions

• Risks to Patients with Serious Cardiac Disease: Avoid use in patients with known structural cardiac abnormalities, cardiomyopathy, serious cardiac arrhythmias, coronary artery disease, or other serious cardiac disease .

• Increased Blood Pressure and Heart Rate: Monitor blood pressure and pulse at appropriate intervals .

• Psychiatric Adverse Reactions: Prior to initiating treatment, screen patients for risk factors for developing a manic episode. If new psychotic or manic symptoms occur, consider discontinuing treatment .

• Long-Term Suppression of Growth in Pediatric Patients: Closely monitor height and weight in pediatric patients. Those not growing or gaining weight as expected may need treatment interruption .

• Seizures: May lower the convulsive threshold. Discontinue in the presence of seizures .

• Peripheral Vasculopathy, Including Raynaud’s Phenomenon: Careful observation for digital changes is necessary during treatment .

• Serotonin Syndrome: Increased risk when coadministered with serotonergic agents (e.g., SSRIs, SNRIs, triptans). If it occurs, discontinue Adderall XR and initiate supportive treatment .

• Motor and Verbal Tics, and Worsening of Tourette’s Syndrome: Before initiating treatment, assess family history and clinically evaluate patients for tics or Tourette’s syndrome .

Potential Side Effects

Common Side Effects in Children (6-12 years)

The most common adverse reactions (≥5% and with a higher incidence than on placebo) are :

• Loss of appetite

• Insomnia

• Abdominal pain

• Emotional lability

• Vomiting

• Nervousness

• Nausea

• Fever

Common Side Effects in Adolescents (13-17 years)

The most common adverse reactions (≥5% and with a higher incidence than on placebo) are :

• Loss of appetite

• Insomnia

• Abdominal pain

• Weight loss

• Nervousness

Common Side Effects in Adults

The most common adverse reactions (≥5% and with a higher incidence than on placebo) are :

• Dry mouth

• Loss of appetite

• Insomnia

• Headache

• Weight loss

• Nausea

• Anxiety

• Agitation

• Dizziness

• Tachycardia

• Diarrhea

• Asthenia

• Urinary tract infections

Drug Interactions

Monoamine Oxidase Inhibitors (MAOIs)

Concomitant use of MAOIs and CNS stimulants can cause hypertensive crisis. Do not administer Adderall XR concomitantly or within 14 days after discontinuing MAOI .

Serotonergic Drugs

The concomitant use of Adderall XR and serotonergic drugs (e.g., SSRIs, SNRIs, triptans) increases the risk of serotonin syndrome. Initiate with lower doses and monitor patients for signs and symptoms .

CYP2D6 Inhibitors

Concomitant use may increase the exposure of Adderall XR and increase the risk of serotonin syndrome. Monitor patients closely .

Urinary Alkalinizing Agents

Alkalinizing agents (e.g., antacids) increase blood levels and potentiate the action of amphetamine. Avoid coadministration .

Urinary Acidifying Agents

Acidifying agents (e.g., ascorbic acid) lower blood levels and efficacy of amphetamines. Dose adjustment may be required .

Frequently Asked Questions

What is Adderall XR 10mg used for?
Adderall XR 10mg is used to treat Attention Deficit Hyperactivity Disorder (ADHD) in adults and children aged 6 years and older .

What does Adderall XR 10mg look like?
Adderall XR 10mg capsules are blue/blue, capsule/oblong in shape, with the imprint “ADDERALL XR 10 mg” .

What is the starting dose of Adderall XR?
For children and adolescents aged 6-17 years, the starting dose is 10 mg once daily in the morning .

How should I take Adderall XR?
Take it once daily in the morning. Swallow the capsule whole, or open it and sprinkle the contents over applesauce. Avoid afternoon doses to prevent insomnia .

Is Adderall XR a controlled substance?
Yes, Adderall XR is classified as a Schedule II controlled substance due to its high potential for abuse and dependence .

For authoritative information on ADHD and treatment options, visit the U.S. Food and Drug Administration (FDA) and the National Institute of Mental Health (NIMH).